PubRank

S Suissa

Author PubWeight™ 150.18‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The use of beta-agonists and the risk of death and near death from asthma. N Engl J Med 1992 8.53
2 Scientific monograph of the Quebec Task Force on Whiplash-Associated Disorders: redefining "whiplash" and its management. Spine (Phila Pa 1976) 1995 7.70
3 Benzodiazepine use and the risk of motor vehicle crash in the elderly. JAMA 1997 6.12
4 Association of inhaled corticosteroid use with cataract extraction in elderly patients. JAMA 1998 4.44
5 Incidence of and risk factors for falls and injurious falls among the community-dwelling elderly. Am J Epidemiol 1993 4.13
6 A clinical trial of estrogen-replacement therapy after ischemic stroke. N Engl J Med 2001 3.86
7 Relationship between nonphenacetin combined analgesics and nephropathy: a review. Ad Hoc Committee of the International Study Group on Analgesics and Nephropathy. Kidney Int 2000 3.86
8 Inhaled and nasal glucocorticoids and the risks of ocular hypertension or open-angle glaucoma. JAMA 1997 3.47
9 Reference-based pricing of prescription drugs: exploring the equivalence of angiotensin-converting-enzyme inhibitors. CMAJ 1999 2.79
10 Vaccinations and the risk of relapse in multiple sclerosis. Vaccines in Multiple Sclerosis Study Group. N Engl J Med 2001 2.68
11 Anti-rheumatic drug use and risk of serious infections in rheumatoid arthritis. Rheumatology (Oxford) 2007 2.55
12 A population-based, randomized clinical trial on back pain management. Spine (Phila Pa 1976) 1997 2.30
13 Does home visiting prevent childhood injury? A systematic review of randomised controlled trials. BMJ 1996 2.27
14 Hormone replacement therapy use and variations in the risk of breast cancer. BJOG 2008 2.24
15 Last days: a study of the quality of life of terminally ill cancer patients. J Chronic Dis 1986 2.24
16 Increased morbidity and mortality related to asthma among asthmatic patients who use major tranquillisers. BMJ 1996 2.20
17 Clinical interpretation of airway response to a bronchodilator. Epidemiologic considerations. Am Rev Respir Dis 1988 2.15
18 The benefits of treating hyperlipidemia to prevent coronary heart disease. Estimating changes in life expectancy and morbidity. JAMA 1992 1.98
19 First treatment with inhaled corticosteroids and the prevention of admissions to hospital for asthma. Thorax 1998 1.90
20 Is the association between inhaled beta-agonist use and life-threatening asthma because of confounding by severity? Am Rev Respir Dis 1993 1.82
21 Counting, analysing and reporting exacerbations of COPD in randomised controlled trials. Thorax 2007 1.81
22 Double blind randomized clinical trial examining the efficacy of bupivacaine suprascapular nerve blocks in frozen shoulder. J Rheumatol 2000 1.73
23 Predicting arterial oxygenation during one-lung anaesthesia. Can J Anaesth 1992 1.66
24 Evaluation of the efficacy of simulation games in traffic safety education of kindergarten children. Am J Public Health 1989 1.66
25 Confounding by indication and channeling over time: the risks of beta 2-agonists. Am J Epidemiol 1996 1.65
26 Importance and economic burden of occupational back pain: a study of 2,500 cases representative of Quebec. J Occup Med 1987 1.55
27 Low-dose inhaled corticosteroids and the risk of acute myocardial infarction in COPD. Eur Respir J 2005 1.53
28 Predictors of one year outcome in lupus nephritis: the importance of renal biopsy. Q J Med 1991 1.52
29 Lung function decline in COPD trials: bias from regression to the mean. Eur Respir J 2008 1.49
30 Exacerbations and intent-to-treat analyses in randomised trials. Eur Respir J 2008 1.39
31 Inhaled corticosteroids in COPD: the case against. Eur Respir J 2009 1.33
32 The effect of socio-demographic and crash-related factors on the prognosis of whiplash. J Clin Epidemiol 1998 1.31
33 Falls among the elderly: distinguishing indoor and outdoor risk factors in Canada. J Epidemiol Community Health 1994 1.23
34 Risk of recurrence of occupational back pain over three year follow up. Br J Ind Med 1988 1.22
35 Respiratory health of a population living downwind from natural gas refineries. Am Rev Respir Dis 1989 1.22
36 Risk of fatal and near-fatal asthma in relation to inhaled corticosteroid use. JAMA 1993 1.21
37 Antihypertensive drug therapy in Saskatchewan: patterns of use and determinants in hypertension. Arch Intern Med 2001 1.21
38 Anti-rheumatic drug use and risk of hospitalization for congestive heart failure in rheumatoid arthritis. Rheumatology (Oxford) 2005 1.20
39 Low-dose inhaled and nasal corticosteroid use and the risk of cataracts. Eur Respir J 2006 1.20
40 Hormone replacement therapy and acute coronary outcomes: methodological issues between randomized and observational studies. Hum Reprod 2004 1.20
41 The influence of psychological status on respiratory symptom reporting. Am Rev Respir Dis 1989 1.17
42 Risk of ocular hypertension or open-angle glaucoma in elderly patients on oral glucocorticoids. Lancet 1997 1.17
43 Working disability due to occupational back pain: three-year follow-up of 2,300 compensated workers in Quebec. J Occup Med 1988 1.14
44 Malignancies in the rheumatoid arthritis abatacept clinical development programme: an epidemiological assessment. Ann Rheum Dis 2008 1.12
45 Long-acting beta-agonists: a review of formoterol safety data from asthma clinical trials. Eur Respir J 2008 1.11
46 Inhaled corticosteroids and the prevention of readmission to hospital for asthma. Am J Respir Crit Care Med 1998 1.10
47 Concern on quality-of-life analysis in the OPTIMAL study. Ann Oncol 2013 1.07
48 End of New Zealand asthma epidemic. Lancet 1995 1.05
49 The influence of systemic glucocorticoid therapy upon the risk of non-serious infection in older patients with rheumatoid arthritis: a nested case-control study. Ann Rheum Dis 2011 1.04
50 Back school in a first episode of compensated acute low back pain: a clinical trial to assess efficacy and prevent relapse. Arch Phys Med Rehabil 1996 0.96
51 The impact of combined inhaled bronchodilator therapy in the treatment of COPD. Chest 2001 0.95
52 Impact of SMBG on control of diabetes as measured by HbA1. 3-yr survey of a juvenile IDDM clinic. Diabetes Care 1988 0.95
53 Inhaled corticosteroids and hospitalisation due to exacerbation of COPD. Eur Respir J 2003 0.94
54 Factors predicting course of beta-cell function in IDDM. Diabetes Care 1992 0.93
55 Hormone replacement therapy and the risk of venous thromboembolism: a population-based study. J Thromb Haemost 2010 0.93
56 Severe hypoglycemia in IDDM children. Diabetes Care 1989 0.93
57 Use of tamoxifen and aromatase inhibitors in a large population-based cohort of women with breast cancer. Br J Cancer 2011 0.93
58 The use of inhaled corticosteroids in the United Kingdom and the Netherlands. Respir Med 2003 0.93
59 Screening for hypercholesterolemia among Canadians: how much will it cost? CMAJ 1991 0.92
60 Testing various methods of introducing health charts into medical records in family medicine units. CMAJ 1991 0.91
61 The pharmacoepidemiology of COPD: recent advances and methodological discussion. Eur Respir J Suppl 2003 0.89
62 Parental smoking and risk of otitis media in pre-school children. Can J Public Health 1996 0.88
63 Clinical experience with a single field rotational total skin electron irradiation technique for cutaneous T-cell lymphoma. Radiother Oncol 1992 0.88
64 Application of an Euclidian distance measure to the selection of reference areas in epidemiologic research concerning environmental issues. Scand J Work Environ Health 1988 0.87
65 Maternal smoking and childhood asthma. Am J Epidemiol 1999 0.87
66 Hip fractures attributable to corticosteroid use. Study of Osteoporotic Fractures Group. Lancet 1999 0.87
67 Prospective study of predictors of beta-cell survival in type I diabetes. Diabetes 1988 0.86
68 The relationship of retinal vessel diameter to changes in diabetic nephropathy structural variables in patients with type 1 diabetes. Diabetologia 2010 0.86
69 Exposure to allopurinol and the risk of cataract extraction in elderly patients. Arch Ophthalmol 1998 0.86
70 Case-control study of hydrocarbon exposures in patients with renal cell carcinoma. CMAJ 1989 0.85
71 Antimalarial drugs and malignancy: no evidence of a protective effect in rheumatoid arthritis. Ann Rheum Dis 2008 0.84
72 Chronic exposure to sour gas emissions: meeting a community concern with epidemiologic evidence. CMAJ 1989 0.84
73 The clinical utility of serum lactate dehydrogenase in diagnosing pneumocystis carinii pneumonia among hospitalized AIDS patients. Clin Invest Med 1992 0.84
74 Bowel obstruction in patients with ovarian cancer: a search for prognostic factors. Am J Obstet Gynecol 1988 0.84
75 Selection of controls in database case-control studies: glucocorticoids and the risk of glaucoma. J Clin Epidemiol 1998 0.83
76 Meta-analysis comparing newer antipsychotic drugs for the treatment of schizophrenia: evaluating the indirect approach. Clin Ther 2001 0.83
77 Clinical complexity and epidemiologic uncertainty in case-control research. Fenoterol and asthma management. Chest 1991 0.82
78 The evolution of compensated occupational spinal injuries. A three-year follow-up study. Spine (Phila Pa 1976) 1992 0.80
79 Metaiodobenzylguanidine [131I] scintigraphy detects impaired myocardial sympathetic neuronal transport function of canine mechanical-overload heart failure. Circ Res 1987 0.79
80 Biases in the observational study of beta blockers in COPD. Thorax 2008 0.79
81 Inhaled corticosteroids and the risk of a first exacerbation in COPD patients. Eur Respir J 2004 0.79
82 Fenoterol and death from asthma. Med J Aust 1992 0.79
83 Inhaled corticosteroids and mortality in COPD. Thorax 2006 0.78
84 Mortality in sleep apnea patients: a multivariate analysis of risk factors--a response to Lavie and collaborators. Sleep 1997 0.78
85 First lifetime back pain and psychiatry treatment: psychological factors and recovery in compensated workers. AAOHN J 2000 0.78
86 A survey of worksite health promotion in Montreal. Can J Public Health 1988 0.78
87 Furosemide use and hospitalization for benign prostatic hyperplasia. Can J Clin Pharmacol 2006 0.78
88 Predicting nocturnal hypoglycemia in patients with type I diabetes treated with continuous subcutaneous insulin infusion. Am J Med 1987 0.77
89 Four-year results of a youth smoking prevention program using assertiveness training. Adolescence 1986 0.77
90 Predicting arterial oxygenation during one-lung ventilation with continuous positive airway pressure to the nonventilated lung. J Cardiothorac Anesth 1990 0.77
91 Asthma deaths in New Zealand. BMJ 1992 0.77
92 NNT, number needed to treat: does it have any real value? Climacteric 2012 0.77
93 Can experienced clinicians predict the outcome of lupus nephritis? Lupus 1992 0.76
94 Brain stem tumors in children: results of a survey of 62 patients treated with radiotherapy. Int J Radiat Oncol Biol Phys 1986 0.76
95 Risk of hypoglycemia with antihypertensive medication. JAMA 1997 0.75
96 Commentary on 'Hormone replacement therapy use and variations in the risk of breast cancer'. BJOG 2008 0.75
97 Albuterol in mild asthma. N Engl J Med 1997 0.75
98 Comparison of inhaled beclomethasone and budesonide. Studies of potencies of asthma drugs have methodological limitations. BMJ 1999 0.75
99 N-acetylcysteine is unlikely to reduce hospitalisation for chronic obstructive pulmonary disease. Eur Respir J 2003 0.75
100 Ventricular arrhythmias and nonsedating antihistamines. Br J Clin Pharmacol 2000 0.75
101 Antibiotic use and the development of Crohn's disease: methodological issues. Gut 2004 0.75
102 Inhaled corticosteroids and the risk of cataracts. N Engl J Med 1997 0.75
103 Beta-agonist use and death from asthma. JAMA 1994 0.75
104 The asthma death problem revisited. Br J Clin Pharmacol 1997 0.75
105 [Sclerotic plaques and hepatitis B vaccination in adults: the situation in 2004. Response]. Rev Neurol (Paris) 2005 0.75
106 Determinants of preventive practices of general practitioners in Torino, Italy. Am J Prev Med 1993 0.75
107 Proliferative characteristics of chronic crypt cells in C57BL/6J and A/J mice as predictors of subsequent tumor formation. Cancer Res 1987 0.75
108 The Toronto Junction Triangle Health Study: a response to a community health emergency. Can J Public Health 1986 0.75
109 Lipodystrophy and nucleoside analogue therapy in HIV-infected patients: important question, few valid answers. J Acquir Immune Defic Syndr 2000 0.75
110 A study of mortality near sour gas refineries in southwest Alberta: an epidemic unrevealed. Can J Public Health 1990 0.75
111 Prediction of the left ventricular ejection fraction response to doxorubicin using a multiple linear regression model. Can J Cardiol 1990 0.75
112 Further examination of the reliability of the Modified Rathus Assertiveness Schedule. Adolescence 1986 0.75
113 Antihypertensives and myocardial infarction risk: the modifying effect of history of drug use. Pharmacoepidemiol Drug Saf 2001 0.75
114 Radiation response of haematopoietic cell lines of human origin. Int J Radiat Biol Relat Stud Phys Chem Med 1986 0.75
115 A multinational evaluation of the efficacy, safety and acceptability of the Protectaid contraceptive sponge. Eur J Contracept Reprod Health Care 2001 0.75
116 Sex-specific criteria for interpretation of thallium-201 myocardial uptake and washout studies. J Nucl Med 1986 0.75
117 Weight changes of male dairy calves following zeranol implants. J Dairy Sci 1983 0.75
118 Study designs of adverse events in asthma treatment. Eur Respir J 1992 0.75
119 Beta-agonists and asthma research: an international consultation. Eur Respir J 1993 0.75